Molsidomine

CAS No. 25717-80-0

Molsidomine( Corvaton | Morsydomine )

Catalog No. M13777 CAS No. 25717-80-0

Molsidomine is an orally active, long acting vasodilating drug, metabolized in the liver to the active metabolite linsidomine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
100MG Get Quote In Stock
200MG 28 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Molsidomine
  • Note
    Research use only, not for human use.
  • Brief Description
    Molsidomine is an orally active, long acting vasodilating drug, metabolized in the liver to the active metabolite linsidomine.
  • Description
    Molsidomine is an orally active, long acting vasodilating drug, metabolized in the liver to the active metabolite linsidomine, which is an unstable compound that releases nitric oxide (NO) upon decay as the actual vasodilating compound.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Corvaton | Morsydomine
  • Pathway
    NF-κB
  • Target
    NOD
  • Recptor
    NOD
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    25717-80-0
  • Formula Weight
    242.23
  • Molecular Formula
    C9H14N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in Water
  • SMILES
    O=C([N-]C1=C[N+](N2CCOCC2)=NO1)OCC
  • Chemical Name
    (ethoxycarbonyl)(3-morpholino-1,2,3-oxadiazol-3-ium-5-yl)amide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rosenkranz B, et al. Clin Pharmacokinet. 1996 May;30(5):372-84.
molnova catalog
related products
  • Arglabin

    Arglabin is a natural product isolated from Artemisia glabella, is a NLRP3 inflammasome inhibitor, has anti-atherogenic and anticancer effects.

  • Nodinitib-1

    A potent and selective NOD1 inhibitor with IC50 of 0.56 uM.

  • BMS986299

    BMS986299 is a modulator of NLRP3 with an EC50 of 1.28 μM and can be used in studies about NLRP3 signaling and the treatment of associated diseases.